Cargando…
3‐Methylglutaconyl‐CoA hydratase deficiency: When ascertainment bias confounds a biochemical diagnosis
3‐Methylglutaconyl‐CoA hydratase deficiency (MGA1) is a defect in leucine catabolism, which causes the accumulation of urinary 3‐methylglutaconate, with or without 3‐hydroxyisovalerate and 3‐methylglutarate. It is an ultra‐rare condition, with <30 cases published in the literature. It is unclear...
Autores principales: | Hertzog, Ashley, Selvanathan, Arthavan, Pandithan, Dinusha, Kim, Won‐Tae, Kava, Maina P., Boneh, Avihu, Coman, David, Tolun, Adviye Ayper, Bhattacharya, Kaustuv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626669/ https://www.ncbi.nlm.nih.gov/pubmed/36341175 http://dx.doi.org/10.1002/jmd2.12332 |
Ejemplares similares
-
A narrative review of metabolomics in the era of “-omics”: integration into clinical practice for inborn errors of metabolism
por: Hertzog, Ashley, et al.
Publicado: (2022) -
Intronic variants in inborn errors of metabolism: Beyond the exome
por: Hertzog, Ashley, et al.
Publicado: (2022) -
A serendipitous journey to a promoter variant: The c.‐106C>A variant and its role in late‐onset ornithine transcarbamylase deficiency
por: Hertzog, Ashley, et al.
Publicado: (2022) -
Treatment of HMG-CoA Lyase Deficiency—Longitudinal Data on Clinical and Nutritional Management of 10 Australian Cases
por: Thompson, Susan, et al.
Publicado: (2023) -
3-Methylglutaconyl-Coenzyme-A Hydratase Deficiency and the Development of Dilated Cardiomyopathy
por: Spergel, Craig D., et al.
Publicado: (2014)